Several chemotherapy agents have been investigated for neoadjuvant use in HER2-positive breast cancer.
Laura Panjwani, OncLive
Advertisement
Articles by Laura Panjwani, OncLive
Advertisement
Latest Updated Articles
The Changing Landscape of Breast Cancer TreatmentPublished: March 1st 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
3
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
